| Literature DB >> 10581597 |
T Kanazawa1, M Shimizu, H Seto, M Kageyama, K Kameda, S Toyoshima, G Tomizawa, N Watanabe, S Inagaki.
Abstract
The aim of this study was to evaluate the reproducibility of 99Tcm-mercaptoacetyltriglycine (99Tcm-MAG3) clearance and to compare it with that of 131I-orthoiodohippurate (131I-OIH), which is widely used in clinical practice. Twelve young healthy volunteers with a mean age of 23.4 years (range 19-28) were enrolled in the study. The investigations were repeated at an interval of 1 month under similar physiological conditions. Each volunteer received a simultaneous injection of 99Tcm-MAG3 and 131I-OIH that was commercially available in an already labelled form. Blood samples were obtained at 44 and 104 min post-injection. Clearance values were calculated using the two-sample method. The mean (+/- S.D.) change from the first to the second measurement was -7.1 +/- 11.1% for 99Tcm-MAG3 and 1.7 +/- 13.6% for 131I-OIH. There were no significant differences between the first and the second measurements of 99Tcm-MAG3 and 131I-OIH clearance, respectively. 99Tcm-MAG3 clearance was shown to be very similar to that of 131I-OIH in healthy volunteers.Entities:
Mesh:
Substances:
Year: 1998 PMID: 10581597 DOI: 10.1097/00006231-199809000-00011
Source DB: PubMed Journal: Nucl Med Commun ISSN: 0143-3636 Impact factor: 1.690